FDA Drug Application (050420) for RIFADIN by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number050420
Product Number001
FormCAPSULE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIFADIN
Active IngredientRIFAMPIN

Active IngredientCount
List of drugs with Active Ingredient RIFAMPIN6


Back to FDA Applications sponsored by SANOFI AVENTIS US